Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Strickland

Showing results (321-330 of 332) with videos related to

Pageof 34
Sort By:
Frontiers in Digital Health|December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancerHeidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
Journal of Translational Medicine|February 7, 2024
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancerR J Seager, Maria-Fernanda Senosain, Erik Van Roey, et al.
Frontiers in Psychiatry|January 24, 2022
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu ReceptorMark A Smith, Shannon L Ballard, Clarise F Ballesteros, et al.
Breast Cancer (Dove Medical Press)|August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast CancerHeidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
The New England Journal of Medicine|November 9, 2022
In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's DiseaseJennifer L Cohen, Pranesh Chakraborty, Karen Fung-Kee-Fung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium studyAngela Nolin, Morgan D Brown, Samantha M Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2008
Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitorsJ N Cumming, T X Le, S Babu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 12, 2018
Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)Helena M Ditzel, Kyle C Strickland, Emily E Meserve, et al.
Gynecologic Oncology|September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Gynecologic Oncology|May 26, 2026
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249Lindsay M Kuroki, Danielle M Enserro, Heather A Lankes, et al.
Pageof 34

Showing results (321-330 of 332) with videos related to

Sort By:
Pageof 34
Frontiers in Digital Health|December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancerHeidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
Journal of Translational Medicine|February 7, 2024
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancerR J Seager, Maria-Fernanda Senosain, Erik Van Roey, et al.
Frontiers in Psychiatry|January 24, 2022
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu ReceptorMark A Smith, Shannon L Ballard, Clarise F Ballesteros, et al.
Breast Cancer (Dove Medical Press)|August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast CancerHeidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
The New England Journal of Medicine|November 9, 2022
In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's DiseaseJennifer L Cohen, Pranesh Chakraborty, Karen Fung-Kee-Fung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium studyAngela Nolin, Morgan D Brown, Samantha M Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2008
Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitorsJ N Cumming, T X Le, S Babu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 12, 2018
Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)Helena M Ditzel, Kyle C Strickland, Emily E Meserve, et al.
Gynecologic Oncology|September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Gynecologic Oncology|May 26, 2026
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249Lindsay M Kuroki, Danielle M Enserro, Heather A Lankes, et al.
Pageof 34